267 related articles for article (PubMed ID: 27906438)
1. Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs as Alzheimer's disease therapies: an updated umbrella review of systematic reviews and meta-analyses.
Wang CH; Wang LS; Zhu N
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4801-4817. PubMed ID: 27906438
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.
Majidazar R; Rezazadeh-Gavgani E; Sadigh-Eteghad S; Naseri A
Eur J Clin Pharmacol; 2022 Oct; 78(10):1567-1587. PubMed ID: 35881170
[TBL] [Abstract][Full Text] [Related]
3. Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.
Kishi T; Matsunaga S; Oya K; Nomura I; Ikuta T; Iwata N
J Alzheimers Dis; 2017; 60(2):401-425. PubMed ID: 28922160
[TBL] [Abstract][Full Text] [Related]
4. [Drug therapy for Alzheimer's disease].
Shoji M
Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
6. Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.
Kennedy RE; Cutter GR; Fowler ME; Schneider LS
JAMA Netw Open; 2018 Nov; 1(7):e184080. PubMed ID: 30646339
[TBL] [Abstract][Full Text] [Related]
7. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect.
Miguel-Álvarez M; Santos-Lozano A; Sanchis-Gomar F; Fiuza-Luces C; Pareja-Galeano H; Garatachea N; Lucia A
Drugs Aging; 2015 Feb; 32(2):139-47. PubMed ID: 25644018
[TBL] [Abstract][Full Text] [Related]
9. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S
Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis.
Wang J; Tan L; Wang HF; Tan CC; Meng XF; Wang C; Tang SW; Yu JT
J Alzheimers Dis; 2015; 44(2):385-96. PubMed ID: 25227314
[TBL] [Abstract][Full Text] [Related]
12. The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.
Deardorff WJ; Feen E; Grossberg GT
Drugs Aging; 2015 Jul; 32(7):537-47. PubMed ID: 26033268
[TBL] [Abstract][Full Text] [Related]
13. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.
Buckley JS; Salpeter SR
Drugs Aging; 2015 Jun; 32(6):453-67. PubMed ID: 25941104
[TBL] [Abstract][Full Text] [Related]
14. Disease-modifying therapies in Alzheimer's disease: how far have we come?
Hüll M; Berger M; Heneka M
Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
[TBL] [Abstract][Full Text] [Related]
15. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
Haywood WM; Mukaetova-Ladinska EB
Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
[TBL] [Abstract][Full Text] [Related]
16. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
Kavirajan H; Schneider LS
Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Sepehry AA; Sarai M; Hsiung GR
Can J Neurol Sci; 2017 May; 44(3):267-275. PubMed ID: 28148339
[TBL] [Abstract][Full Text] [Related]
19. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
[TBL] [Abstract][Full Text] [Related]
20. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease.
Diniz BS; Pinto JA; Gonzaga ML; Guimarães FM; Gattaz WF; Forlenza OV
Eur Arch Psychiatry Clin Neurosci; 2009 Jun; 259(4):248-56. PubMed ID: 19224111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
